Interestingly, in melanoma cells, histone demethylase LSD1 inhibition increases repetitive element expression and anti-tumour immunity response [39], suggesting that its pharmacological targeting may be a promising strategy to enhance innate immune response in cancers. Here, KDM1A is linked to cancer.